Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal duration of antibiotic treatment in complicated parapneumonic pleural effusion or empyema
2014-003137-25Phase 4Active
- Sponsor
- Hospital Universitari Arnau de Vilanova
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin and clavulanic acid in parapneumonic effusion and empyema (2 arms), sponsored by Hospital Universitari Arnau de Vilanova. Primary endpoint: Healing at 3 months. Started Oct 2014; status: active.
02
Drugs
amoxicillinclavulanic acid
03
Conditions
parapneumonic effusionempyema
Beyond the preview
Go deeper on 2014-003137-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003137-25.